Siirry offline-tilaan Player FM avulla!
Highlights at AACR 2023: mRNA vaccines in melanoma and novel RAF inhibitors
Manage episode 374905000 series 2424442
In this podcast, we’ll be covering highlights from the American Association for Cancer Research (AACR) Annual Meeting 2023 in Orlando, FL, including personalized mRNA and neoantigen vaccines, nivolumab with the standard of care in prostate cancer, and BGB-3245, a novel RAF dimer inhibitor, in solid tumors. Hear from Jeffrey Weber, NYU Langone Perlmutter Cancer Center, NY, Mansi Saxena, Icahn School of Medicine at Mount Sinai, New York, NY, John Michael Bryant, Moffitt Cancer Center, Tampa, FL, and Alison Schram, Memorial Sloan Kettering Cancer Center, New York, NY, who will all talk on these exciting advances.
The post Highlights at AACR 2023: mRNA vaccines in melanoma and novel RAF inhibitors appeared first on VJOncology.
179 jaksoa
Manage episode 374905000 series 2424442
In this podcast, we’ll be covering highlights from the American Association for Cancer Research (AACR) Annual Meeting 2023 in Orlando, FL, including personalized mRNA and neoantigen vaccines, nivolumab with the standard of care in prostate cancer, and BGB-3245, a novel RAF dimer inhibitor, in solid tumors. Hear from Jeffrey Weber, NYU Langone Perlmutter Cancer Center, NY, Mansi Saxena, Icahn School of Medicine at Mount Sinai, New York, NY, John Michael Bryant, Moffitt Cancer Center, Tampa, FL, and Alison Schram, Memorial Sloan Kettering Cancer Center, New York, NY, who will all talk on these exciting advances.
The post Highlights at AACR 2023: mRNA vaccines in melanoma and novel RAF inhibitors appeared first on VJOncology.
179 jaksoa
Kaikki jaksot
×Tervetuloa Player FM:n!
Player FM skannaa verkkoa löytääkseen korkealaatuisia podcasteja, joista voit nauttia juuri nyt. Se on paras podcast-sovellus ja toimii Androidilla, iPhonela, ja verkossa. Rekisteröidy sykronoidaksesi tilaukset laitteiden välillä.